Streetbeat News

Stock Prices

ZS

Zscaler shares are trading lower after the company reported its Q4 earnings. Additionally, Needham and Baird have both lowered their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:37 am

CME

CME Group reported a 31% increase in average daily volume (ADV) in August, reaching 31.7 million contracts. The company set multiple ADV records across asset classes, including interest rates, equity index, agricultural, and foreign exchange.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:36 am

AIRL

JETS

LUV

Southwest Airlines (NYSE:LUV) shares are trading slightly higher premarket after reporting zero cancellations on Labor Day and strong summer performance. Elliott Investment Management, holding an 11% stake, plans to nominate new board members. Investors can also gain exposure through ETFs like JETS and AIRL.

Portfolio Pulse from Lekha Gupta

September 04, 2024 | 11:36 am

HRL

Hormel Foods shares declined following the release of mixed Q3 financial results and a reduction in FY24 sales guidance, with the midpoint falling below analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:35 am

SHFS

Safe Harbor Financial, a subsidiary of SHF Holdings, Inc. (NASDAQ:SHFS), has restructured executive contracts to save $350,000. The restructuring includes extending contracts for key executives and shifting compensation towards performance-based incentives.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:35 am

BIIB

Biogen Inc. announced positive results from a Phase 2/3 study of a higher dose regimen of nusinersen for infants with spinal muscular atrophy, showing significant improvement in motor function.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:33 am

AZN

NVO

VANI

Vivani Medical (NASDAQ:VANI) reported positive preclinical results for its exenatide implant, showing significant liver fat reduction in obese mice. The implant, which could be a promising treatment for obesity, is set to begin clinical trials in late 2024. The news led to a 7.32% increase in VANI's stock price.

Portfolio Pulse from Vandana Singh

September 04, 2024 | 11:33 am

VANI

Vivani Medical announced that its GLP-1 (exenatide) implant achieved an 82% reduction in liver fat in an obese mouse model with a single administration, suggesting potential for twice-yearly dosing.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:30 am

APH

Amphenol's stock is experiencing a decline following a downgrade by B of A Securities from Buy to Neutral, with a reduced price target from $80 to $71.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:30 am

NVDA

SPY

USO

U.S. stocks experienced a significant decline, with the S&P 500, Nasdaq, and Dow seeing their steepest losses since early August. Nvidia's sharp drop of nearly 10% contributed to the broader market decline. Weaker manufacturing data and uncertainty over Federal Reserve interest rate cuts dampened investor sentiment. Most S&P 500 sectors fell, particularly energy, tech, and communication services, while real estate and consumer staples gained. Asian and European markets also saw declines, and crude oil prices fell below $70.

Portfolio Pulse from Akanksha Bakshi

September 04, 2024 | 11:26 am